ZURA
Zura BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ZURA Profile
Zura Bio Limited
A biotechnology company researching the clinical stage of alopecia areata and other inflammatory diseases, as well as chronic obstructive pulmonary disease and asthma
1489 W. Warm Springs Rd. #110, Henderson, NV 89014
--
Zura Bio Limited was established in January 2022. The company is a clinical-stage, multi-asset immunology company dedicated to the development of novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases with unmet needs. With the team's extensive experience, the company identifies relevant diseases and develops differentiated assets in these diseases. The company's strategic focus is to leverage the power of dual-pathway organisms to provide broader and deeper clinical benefits to patients with autoimmune and inflammatory diseases.
